Site updated at Wednesday, 22 June 2016

Living with Dementia

Memory Disorders

Clinical Conclusions

Using an evidence-based review of the literature, the Quality Standards Subcommittee of the American Academy of Neurology made three levels of recommendation for clinical practice related to the diagnosis and evaluation of individuals with mild cognitive impairment and dementia (Knopman et al. 2001; Petersen et al. 2001): standards were based on patient management… Clinical Conclusions   

A micro-RNA as a key regulator of learning and Alzheimer’s disease

Proteins are the molecular machines of the cell. They transport materials, cleave products or transmit signals - and for a long time, they have been a main focus of attention in molecular biology research. In the last two decades, however, another class of critically important molecules has emerged: small RNA molecules, including micro-RNAs. It… A micro-RNA as a key regulator of learning and Alzheimer’s disease   

Living with Dementia: I’m Still Here

memory skills1 - selective serotonin reuptake inhibitor2 - alcoholic encephalopathy10 - psychomotor retardation1 - dbs1 - neurotransmitter1 - good quality care1 - protein amyloid beta1 - brain functions in patients1 - hospice2 - parkinson's disease protein1 - grandiosity1 - neuropsychological evaluations1 - induced pluripotent stem cells1 - subjective cognitive decline1 - early-onset alzheimer's1 - parkinson's drug2 - small-vessel cerebrovascular disease1 - exelon1 - incident dementia1 - quit smoking1 - terminal cognitive failure1 - lewis and short1 - vascular damage1 - morphometry1 - memory losses1 - thinking abilities1 - overweight people1 - vascular health1 - lrp61 -